http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113368045-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-107
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
filingDate 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2023-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2023-01-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-113368045-B
titleOfInvention A drug-loaded nanomicelle responsive to magnetic oxidation and its preparation method and application
abstract The invention relates to the field of nanomedicine, in particular to a magnetic oxidation-responsive drug-loaded nano-micelle and a preparation method and application thereof. The magnetic oxidation-responsive drug-loaded nanomicelle provided by the present invention loads oil-soluble Fe 3 O 4 nanoparticles in a micelle system, which can be wrapped in the hydrophobic core of the oxidation-sensitive micelle. In an oxidizing environment, the micelles are oxidized to disassemble and release Fe3O4 nanoparticles to achieve nanoscale conversion. The loaded drug is released quickly after reaching the target site, shortening the residence time in the body. The application of it in the transport carrier of anti-tumor drugs can realize the effective transportation of nano drug particles in the process of blood circulation and the accumulation inside the tumor, and enhance the penetration of anti-tumor drugs to tumors.
priorityDate 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5483663
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID85779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411091275
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421209249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14072
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456986878
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414836370
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4463282
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447648849
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393641
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7657
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447527008
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5356789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414874739

Total number of triples: 43.